Trades on 2 secondary markets

Aktis Oncology

Aktis Oncology is a clinical-stage biotechnology company developing next-generation precision radiopharmaceuticals for the treatment of cancer. The company has built a proprietary miniprotein radioconjugate platform that pairs tumor-targeting miniproteins with targeted alpha-particle emitters, aimin

minimal 14.6 / 100 0 APIs View provider profile →
CompanyBiotechnologyPharmaceuticalsOncologyRadiopharmaceuticalsPrecision Medicine

Aktis Oncology is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.